29 April 2023
Latham Advises CHEPLAPHARM on €750 Million High Yield Bond
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Christoph Engeler Lead | Latham & Watkins LLP | Partner | Not stated | Hamburg |
| Rüdiger Malaun Lead | Latham & Watkins LLP | Partner | Not stated | Frankfurt |
| Alexandra Hagelüken | Latham & Watkins LLP | Partner | Not stated | Frankfurt |
| Jan Penselin | Latham & Watkins LLP | Partner | Not stated | Frankfurt |
| Isabel Willius | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Ulf Kieker | Latham & Watkins LLP | Partner | tax | Munich |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 750m (€750 million)
- What the figure measures
- Issue size
- Client
- CHEPLAPHARM Arzneimittel GmbHIssuer
- Counterparties
- Eli Lilly and Company (Other)